Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 3.09 Billion | USD 7.40 Billion | 10.2% | 2023 |
The global veterinary stereotactic radiosurgery market size was worth around USD 3.09 Billion in 2023 and is predicted to grow to around USD 7.40 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 10.2% between 2024 and 2032. The report analyzes the global veterinary stereotactic radiosurgery market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the veterinary stereotactic radiosurgery industry.
Veterinary Stereotactic Radiosurgery Market: Segmentation Analysis
The study provides a decisive view of the Veterinary Stereotactic Radiosurgery market by segmenting the market based on Type, Modality, Product and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
Based on the Modality segment, the market is bifurcated CyberKnife, Gamma Knife, LINAC, PBRT and Others. In 2023, Particle Beam Radiation Therapy (PRBT) held the largest revenue share in the market. Some of the primary growth drivers for the segment are advantages such as reduced irradiation for healthy tissue and effective treatment even with low radiation doses. According to a 2018 article in the Journal of Hematology & Oncology, Proton Beam Therapy for Cancer in the Age of Precision Medicine, PRBT delivers the radiation dose on a tumor cell and deliberates to the surrounding tissue and organs with very little or no irradiation effect. The treatment results in maximum control of the tumor and ultimately reduces the toxicity of the tumor. Thanks to its increased adoption for veterinary use, LINAC-based stereotactic radiosurgery therapy adopted PBRT.
In 2017, the Veterinary CyberKnife Cancer Center constructed a linear Varian accelerator for cancerous tumor treatment of dogs. To irradiate various forms of cancer, the mounted LINAC system supplemented the Cyber Knife software. Increasing the use of the LINAC-based radiosurgery system as an animal treatment method fosters the development of the demand for veterinary stereotactic radiosurgery systems.
Veterinary Stereotactic Radiosurgery Market: Regional Analysis
The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the market over the forecast period, owing to the increasing incidence of cancer in the pet population, increasing pet companionship along with an increase in willingness to spend on their pets, and government initiatives to treat SRT. The involvement of non-profit organizations such as APPA catering to pet products and services needs and interests further drive regional market growth.
Increasing research studies to test the safety and efficacy of SRT in animals are also driving North America's market growth. In terms of revenue over the forecast period, Europe's market for veterinary stereotactic radiosurgery systems is expected to be the second-largest regional segment. Government R&D initiatives and the establishment of new centers to carry out veterinary radiation oncology research activities are the factors expected to fuel growth.
Asia Pacific had the third-largest market share in 2023 and is expected to see significant growth over the forecast period due to increased awareness of various pet treatment methods, a willingness to spend more on veterinary health, and an increasing number of animal health awareness programs. Due to the increasing incidence of euthanasia and pet subscriptions, the Middle East and Africa held a very small market share of SRT treatment, and despite economic and political issues in the region, the pet industry has remained resilient over the years.
Report Attributes | Report Details |
---|---|
Report Name | Veterinary Stereotactic Radiosurgery Market |
Market Size in 2023 | USD 3.09 Billion |
Market Forecast in 2032 | USD 7.40 Billion |
Growth Rate | CAGR of 10.2% |
Number of Pages | 230 |
Key Companies Covered | Accuray, Elekta AB, PetCure Oncology, and Varian Medical Systems amongst others |
Segments Covered | By Type, By Modality, By Product and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some of the major players in the global veterinary stereotactic radiosurgery market include:
The global veterinary stereotactic radiosurgery market is segmented as follows;
Global Veterinary Stereotactic Radiosurgery Market: Modality Segment Analysis
Global Veterinary Stereotactic Radiosurgery Market: Regional Segment Analysis
FrequentlyAsked Questions
Veterinary stereotactic radiosurgery (SRS) is a highly precise radiation therapy treatment for animals. It involves delivering a single, high dose of radiation to a tumor or abnormal tissue with minimal damage to surrounding healthy tissue. This advanced technique is used to treat various cancers in pets, including brain tumors, spinal cord tumors, and certain soft tissue tumors.
According to a study, the global veterinary stereotactic radiosurgery market size was worth around USD 3.09 billion in 2023 and is expected to reach USD 7.40 billion by 2032.
The global veterinary stereotactic radiosurgery market is expected to grow at a CAGR of 10.2% during the forecast period.
North America is expected to dominate the veterinary stereotactic radiosurgery market over the forecast period.
Leading players in the global veterinary stereotactic radiosurgery market include Accuray, Elekta AB, PetCure Oncology, and Varian Medical Systems, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed